CS logo
small CS logo
Kim's Eye Hospital

Seoul, Korea, Republic of
Bus stop in Seoul
Seoul

About Kim's Eye Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Kim's Eye Hospital
2
Alcon Research
1
Allergan
1
Asan Medical Center
1
Hugel
1
LitePharmTech Co., Ltd.
1
Santen Pharmaceutical Asia Pte. Ltd.
1
Santen Pharmaceutical Co., Ltd.
1
Total Rows: 9

Clinical Trials at Kim's Eye Hospital


During the past decade, Kim's Eye Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33000000000033220000000000000000Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The High Cup/Disc Ratio in Children
2009-01-01
2013-03-01
Completed
50
ELAZOP Switching Study in Korea
2010-03-01
2011-12-01
Completed
96
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm
2008-04-01
2009-07-01
Completed
172
Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
2013-10-01
2015-05-01
Completed
43
Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
2015-10-19
2018-03-19
Completed
3,423
Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery
2015-09-21
2017-03-31
Completed
576
Intravitreal Aflibercept for Submacular Hemorrhage
2015-12-01
2019-01-20
Completed
29
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
2021-03-02
2023-07-13
Active, not recruiting
729

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kim's Eye Hospital" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Kim's Eye Hospital" with 2 trials sponsored, "Alcon Research" with 1 trials sponsored, "Allergan" with 1 trials sponsored and "Asan Medical Center" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kim's Eye Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 3Hoffmann-La Roche: 3Kim's Eye Hospital: 2Kim's Eye Hospital: 2Alcon Research: 1Alcon Research: 1Allergan: 1Allergan: 1Asan Medical Center: 1Asan Medical Center: 1Hugel: 1Hugel: 1LitePharmTech Co., Ltd.: 1LitePharmTech Co., Ltd.: 1Santen PharmaceuticalAsia Pte. Ltd.: 1Santen PharmaceuticalAsia Pte. Ltd.: 1Santen PharmaceuticalCo., Ltd.: 1Santen PharmaceuticalCo., Ltd.: 1

Created with Highcharts 11.1.0Top CollaboratorsBayer: 1Bayer: 1Chugai Pharmaceutical: 1Chugai Pharmaceutical: 1

Clinical Trials Conditions at Kim's Eye Hospital


According to Clinical.Site data, the most researched conditions in "Kim's Eye Hospital" are "Diabetic Macular Edema" (2 trials), "Cataract Surgery" (1 trials), "Central Retinal Vein Occlusion" (1 trials), "Central Serous Chorioretinopathy" (1 trials) and "Children" (1 trials). Many other conditions were trialed in "Kim's Eye Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Kim's Eye Hospital


Most popular intervention types in "Kim's Eye Hospital" are "Drug" (11 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Sham Procedure" (3 trials), "RO7200220" (2 trials), "Ranibizumab" (2 trials), "Aflibercept" (1 trials) and "Alcaftadine Ophthalmic Solution 0.25%" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kim's Eye Hospital


The vast majority of trials in "Kim's Eye Hospital" are 12 trials for "All" genders.

Clinical Trials Status at Kim's Eye Hospital


Currently, there are NaN active trials in "Kim's Eye Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Kim's Eye Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kim's Eye Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 3Phase 2: 3Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Recruiting: 4Recruiting: 4Active, not recruiting: 1Active, not recruiting: 1